Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation

He, Zhuohao, Guo, Jing L, McBride, Jennifer D, Narasimhan, Sneha, Kim, Hyesung, Changolkar, Lakshmi, Zhang, Bin, Gathagan, Ronald J +9 more·2018·Nature Medicine

Cited by (656)

Items 301–400 of 656

  1. Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases
    Shen-Qing Zhang, Hui Dong, Jiang Bian, Dan Li, Cong Liu · 2022 · Fundamental Research
  2. Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease
    Pei Ou-Yang, Zhiyu Cai, Zhong-Hao Zhang · 2023 · Aging and Disease
  3. Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism
    Jiwei Jiang, Hanping Shi, Shirui Jiang, Anxin Wang, Xinying Zou, Yanli Wang, Wenyi Li, Yuan Zhang, Mengfan Sun, Qiwei Ren et al. · 2023 · Science China Life Sciences
  4. Neurodegenerative effects of air pollutant Particles: Biological mechanisms implicated for Early-Onset Alzheimer’s disease
    Cindy Gunawan, Charlotte L. Fleming, Peter J. Irga, Roong Jien Wong, Rose Amal, Fraser R. Torpy, Mojtaba Golzan, Kristine C. Y. McGrath · 2024 · Environment International
  5. In vivo Evaluation and Alzheimer’s Disease Treatment Outcome of siRNA Loaded Dual Targeting Drug Delivery System
    Chi Zhang, Zhi‐Chun Gu, Long Shen, Xianyan Liu, Hou‐Wen Lin · 2019 · Current Pharmaceutical Biotechnology
  6. Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody
    Kristof Van Kolen, T. Malia, Clara Theunis, Rupesh K. Nanjunda, A. Teplyakov, Robin Ernst, Sheng‐Jiun Wu, Jinquan Luo, Marianne Borgers, Marc Vandermeeren et al. · 2020 · Journal of Alzheimer s Disease
  7. Dietary Fatty Acid Factors in Alzheimer’s Disease: A Review
    Tianying Zhang, Xiaojuan Han, Xiaohua Zhang, Zhi Chen, Yajing Mi, Xingchun Gou · 2020 · Journal of Alzheimer s Disease
  8. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation
    Gloria Biechele, Tanja Blume, Maximilian Deußing, Benedikt Zott, Yuan Shi, Xianyuan Xiang, Nicolai Franzmeier, Gernot Kleinberger, Finn Peters, Katharina Ochs et al. · 2021 · Theranostics
  9. Aducanumab and the “post-amyloid” era of Alzheimer research?
    Erik S. Musiek, David Alan Bennett · 2021 · Neuron
  10. TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo
    Lee-Gosselin, Audrey, Jury-Garfe, Nur, You, Yanwen, Dabin, Luke, Soni, Disha, Dutta, Sayan, Rochet, Jean-Christophe, Kim, Jungsu, Oblak, Adrian L., Lasagna-Reeves, Cristian A. · 2023 · Cells
  11. Increase in Tau Pathology in P290S <i>Mapt</i> Knock-In Mice Crossed with <i>App</i> <sup>NL-G-F</sup> Mice
    Huang, Melissa, Macdonald, Jennifer, Lavenir, Isabelle, Chen, Renren, Craxton, Molly, Slavik-Smith, Elizabeth, Davies, Stephen W., Goedert, Michel · 2022 · eneuro
  12. The new perspective of Alzheimer's Disease Research: Mechanism and therapeutic strategy of neuronal senescence
    Qianqian Niu, Danjie Li, Jiayin Zhang, Zhengji Piao, Yanli Xi, Yuting Xi, Nik Nur Syazni Nik Mohamed Kamal, Peng Li, Peng Li, Yaling Yin · 2024 · Ageing Research Reviews
  13. Cerebrospinal Fluid and Plasma Tau as a Biomarker for Brain Tauopathy
    Mikio Shoji · 2019 · Advances in experimental medicine and biology
  14. Antioxidant and copper-chelating power of new molecules suggested as multiple target agents against Alzheimer's disease. A theoretical comparative study
    Maciej Spiegel, Tiziana Marino, Mario Prejanò, Nino Russo · 2022 · Physical Chemistry Chemical Physics
  15. Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer’s Disease
    SK Chand Basha, Mekala Janaki Ramaiah, K. S. Jagannatha Rao · 2023 · Journal of Alzheimer s Disease
  16. Brain volume, energy balance, and cardiovascular health in two nonindustrial South American populations
    Hillard S Kaplan, Paul L. Hooper, Margaret Gatz, Wendy Jean Mack, E. Meng Law, Helena Chang Chui, M. Linda Sutherland, James D. Sutherland, Christopher J. Rowan, L. Samüel Wann et al. · 2023 · Proceedings of the National Academy of Sciences
  17. New insights into innate immunity in Alzheimer’s disease: From APOE protective variants to therapies
    Chen, Yun, Holtzman, David M. · 2024 · Trends in Immunology
  18. Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis
    Lara Maria Krämer, Johannes Brettschneider, Jochen K. Lennerz, Daniel Walcher, Lubin Fang, Angela Rosenbohm, Karthikeyan Balakrishnan, Julian Benckendorff, Peter Möller, Steffen Just et al. · 2018 · Scientific Reports
  19. Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
    Klaus Grossmann · 2021 · International Journal of Molecular Sciences
  20. What can 7T sodium MRI tell us about cellular energy depletion and neurotransmission in Alzheimer's disease?
    Alexa Haeger, Michel Bottlaender, Julien Lagarde, Renata Porciuncula Baptista, Cécile Rabrait‐Lerman, Volker Luecken, Jörg Bernhard Schulz, Alexandre Vignaud, Marie Sarazin, Kathrin Reetz et al. · 2021 · Alzheimer s & Dementia
  21. Melatonin and zinc supplements with physical and mental activities subside neurodegeneration and hepatorenal injury induced by aluminum chloride in rats: Inclusion of GSK-3β-Wnt/β-catenin signaling pathway
    Karema Abu‐Elfotuh, Furqan H. Hussein, Ashwaq Najemaldeen Abbas, Mohammed Dakhil Al-Rekabi, Samia Soliman Barghash, Sameh S. Zaghlool, Soad Z. El‐Emam · 2022 · NeuroToxicology
  22. Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer’s disease
    Ashish Raj, Justin Torok, Kamalini G. Ranasinghe · 2025 · Progress in Neurobiology
  23. Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation
    Shama Rao, Leelavathi Narayana Madhu, Roshni Sara Babu, Goutham Shankar, Sanya Kotian, Advaidhaa Nagarajan, Raghavendra Upadhya, Esha Narvekar, James J. Cai, Ashok Kumar Shetty · 2025 · Stem Cell Research & Therapy
  24. Autophagy in alzheimer disease pathogenesis and its therapeutic values
    Gabrielle Angst, Nuo Jia, Luis Tron Esqueda, Yanbo Fan, Qian Cai, Chenran Wang · 2025 · Autophagy Reports
  25. Plexin-A4 mediates amyloid-β–induced tau pathology in Alzheimer’s disease animal model
    Sunwoo Chung, Jinhee Yang, Haeng Jun Kim, Eun Mi Hwang, Wonik Lee, K. Y. Suh, Hayoung Choi, Inhee Mook‐Jung · 2021 · Progress in Neurobiology
  26. Aβ and Tau Prions Causing Alzheimer’s Disease
    Carlo Condello, Gregory E. Merz, Atsushi Aoyagi, William F. DeGrado, Stanley B. Prusiner · 2022 · Methods in molecular biology
  27. Ranking the risk factors for Alzheimer’s disease; findings from the UK Biobank study
    Michael Allwright, Hamish D. Mundell, Andrew N. McCorkindale, Richard I. Lindley, Paul J. Austin, Boris Guennewig, Greg Trevor Sutherland · 2023 · Aging Brain
  28. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations
    Xuhua Li, Yujie Chen, Zhiwei Yang, Shengli Zhang, Guanghong Wei, Lei Zhang · 2023 · International Journal of Biological Macromolecules
  29. LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    Ryszard M. Pluta, Janusz Kocki, Jacek Bogucki, Anna Bogucka‐Kocka, Stanisław Jerzy Czuczwar · 2023 · Cells
  30. Lymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission
    Chan Chen, Ramhari Kumbhar, Hu Wang, Xiuli Yang, Kundlik Gadhave, Cyrus T. Rastegar, Yasuyoshi Kimura, Adam A. Behensky, Sumasri Kotha, Grace Kuo et al. · 2024 · Advanced Science
  31. Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo
    Viktoriya G. Krut’, Andrei L. Kalinichenko, Dmitry I. Maltsev, David Jappy, Evgeny K. Shevchenko, Oleg V. Podgorny, Vsevolod Vadimovich Belousov · 2024 · Progress in Neurobiology
  32. Distinctive contribution of two additional residues in protein aggregation of Aβ42 and Aβ40 isoforms
    Dongjoon Im, Tae Su Choi · 2024 · BMB Reports
  33. Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
    Yifan Yu, Shilong Yu, Giuseppe Battaglia, Xiaohe Tian · 2024 · Ibrain
  34. Scenarios for the long‐term efficacy of amyloid‐targeting therapies in the context of the natural history of Alzheimer's disease
    Lars Lau Rakêt, Jeffrey L. Cummings, Alexis Moscoso, Nicolas Villain, Michael Schöll · 2024 · Alzheimer s & Dementia
  35. Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
    Laura Ibáñez, Carlos Cruchaga, María Victoria Fernández · 2021 · Genes
  36. Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
    E. Josephine Boder, Ipsita A. Banerjee · 2021 · Bioengineering
  37. Presubiculum principal cells are preserved from degeneration in knock-in APP/TAU mouse models of Alzheimer’s disease
    Islam, Anam, Saito, Takashi, Saido, Takaomi, Ali, Afia B. · 2023 · Seminars in Cell &amp; Developmental Biology
  38. Concomitant protein pathogenesis in Parkinson’s disease and perspective mechanisms
    Yuliang Han, Zhuohao He · 2023 · Frontiers in Aging Neuroscience
  39. The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis
    Jiaxuan Li, Xin Wu, Xin Tan, Shixin Wang, Ruisi Qu, Xiaofeng Wu, Zhouqing Chen, Zhong Wang, Gang Chen · 2023 · Frontiers in Aging Neuroscience
  40. RETRACTED: Different Amyloid-β Self-Assemblies Have Distinct Effects on Intracellular Tau Aggregation
    Woo Shik Shin, Jing Di, Kevin A. Murray, Chuanqi Sun, Binsen Li, Gal Bitan, Lin Jiang · 2019 · Frontiers in Molecular Neuroscience · Retracted
  41. Targeting Autophagy In Disease: Recent Advances In Drug Discovery
    Dasol Kim, Hui-Yun Hwang, H. Kwon · 2020 · Expert Opinion on Drug Discovery
  42. RETRACTED ARTICLE: The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic
    Mahsa Pourhamzeh, Mohammad Taghi Joghataei, Soraya Mehrabi, Reza Ahadi, Seyed Mohammad Masood Hojjati, Nasrin Fazli, Seyed Massood Nabavi, Hossein Pakdaman, Koorosh Shahpasand · 2020 · Cellular and Molecular Neurobiology · Retracted
  43. Distinct Brain Functional Impairment Patterns Between Suspected Non-Alzheimer Disease Pathophysiology and Alzheimer’s Disease: A Study Combining Static and Dynamic Functional Magnetic Resonance Imaging
    Zheyu Li, Kaicheng Li, Xiao Luo, Qingze Zeng, Shuai Zhao, Baorong Zhang, Minming Zhang, Yanxing Chen, Alzheimer’s Disease Neuroimaging Initiative · 2020 · Frontiers in Aging Neuroscience
  44. Sanweidoukou decoction, a Chinese herbal formula, ameliorates β-amyloid protein-induced neuronal insult via modulating MAPK/NF-κB signaling pathways: Studies in vivo and in vitro
    Feng-Mao An, Zheng Liu, Xinran Xuan, Qingshan Liu, Cheng‐Xi Wei · 2021 · Journal of Ethnopharmacology
  45. Correction of microtubule defects within Aβ plaque‐associated dystrophic axons results in lowered Aβ release and plaque deposition
    Yuemang Yao, Goodwell Nzou, Thibault Alle, Wangchen Tsering, Shaniya Maimaiti, John Q. Trojanowski, Virginia M.‐Y. Lee, Carlo Ballatore, Kurt R. Brunden · 2020 · Alzheimer s & Dementia
  46. Personalised regional modelling predicts tau progression in the human brain
    Pavanjit Chaggar, Jacob W. Vogel, Alexa Pichet Binette, Travis Thompson, Olof T. Strandberg, Niklas Mattsson, Linda Karlsson, Erik Stomrud, Saâd Jbabdi, Stefano Magon et al. · 2025 · PLoS Biology
  47. Relationship of Apolipoprotein E with Alzheimer’s Disease and Other Neurological Disorders: An Updated Review
    Tian-Wen Lou, Borui Tao, Ming Chen · 2023 · Neuroscience
  48. The role of ferritinophagy and ferroptosis in Alzheimer’s disease
    Ziwen Chen, Nan Zheng, Fuwei Wang, Qiong Zhou, Zihao Chen, Lihua Xie, Qiang Sun, Li Li, Baohong Li · 2024 · Brain Research
  49. Rates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain
    Molly R. LaPoint, Suzanne L. Baker, Susan M. Landau, Theresa M. Harrison, William J. Jagust · 2022 · Neurobiology of Aging
  50. Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities
    Angie K. Torres, Rodrigo G. Mira, Cristina Pinto, Nibaldo C. Inestrosa · 2025 · Frontiers in Cellular Neuroscience
  51. Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer’s disease model mice
    Katherine R. Sadleir, Karen Gómez, Abigail E. Edwards, Armana J. Patel, Makenna L. Ley, Ammaarah W. Khatri, Joanna Guo, Shreya Mahesh, Elyse A. Watkins, Jelena Popović et al. · 2025 · Acta Neuropathologica
  52. GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer's disease mouse model.
    Hyunhee Park, H. Kwon, Kyu-Yong Lee, Ye Eun Kim, Jeongu Son, Na-Young Choi, Eun Ji Lee, Myung-Hoon Han, Dong Woo Park, Sangjae Kim et al. · 2023 · Brain, behavior, and immunity
  53. Transformation of non-neuritic into neuritic plaques during AD progression drives cortical spread of tau pathology via regenerative failure
    Wangchen Tsering, Gabriela P. Hery, Jennifer L. Phillips, Kiara Lolo, Tim Bathe, Jonathan Anthony B. Villareal, Isabelle Y. Ruan, Stefan Prokop · 2023 · Acta Neuropathologica Communications
  54. Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure
    Eduardo Pena, Rocio San Martin-Salamanca, Samia El Alam, Karen Flores, Karem Arriaza · 2024 · International Journal of Molecular Sciences
  55. Penetrating Ballistic-Like Brain Injury Leads to MicroRNA Dysregulation, BACE1 Upregulation, and Amyloid Precursor Protein Loss in Lesioned Rat Brain Tissues
    Bharani Thangavelu, Bernard R. Wilfred, David Johnson, Janice S. Gilsdorf, Deborah A. Shear, Angela M. Boutté · 2020 · Frontiers in Neuroscience
  56. Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer’s Disease
    Carmen Romero‐Molina, Victoria Navarro, Sebastián Jiménez, Clara Muñoz‐Castro, Maria Virtudes Sanchez-Mico, Antonia Gutiérrez, Javier Vitórica, Marisa Vizuete · 2021 · International Journal of Molecular Sciences
  57. A novel Lgi1 mutation causes white matter abnormalities and impairs motor coordination in mice
    Xiao‐Yu Teng, Ping Hu, Yangyang Chen, Yan‐Yu Zang, Xiaolian Ye, Jingmin Ou, Guiquan Chen, Yun Stone Shi · 2022 · The FASEB Journal
  58. Neuropathology and cholinesterase expression in the brains of octogenarians and older
    Selena P. Maxwell, Meghan K. Cash, Sultan Darvesh · 2022 · Chemico-Biological Interactions
  59. Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer’s Disease
    Benjamin J. Bell, Medhinee M. Malvankar, Carolyn Tallon, Barbara Stauch Slusher · 2020 · ACS Chemical Neuroscience
  60. A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap
    Victor Z. Lau, Ifeoluwa Oluleke Awogbindin, Dan Frenkel, Shawn Narain Whitehead, Marie‐Ève Tremblay · 2025 · Alzheimer s & Dementia
  61. Targeting Amyloid Beta Aggregation and Neuroinflammation in Alzheimer’s Disease: Advances and Future Directions
    Ioanna Dagla, Faidon Gkikas, Evagelos E. Gikas, Anthony Tsarbopoulos · 2026 · Cells
  62. Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
    Lukai Zheng, Anna Rubinski, J. Denecke, Ying Luan, Ruben A Smith, Olof T. Strandberg, Erik Stomrud, Rik Ossenkoppele, Diana Otero Svaldi, Ixavier Alonzo Higgins et al. · 2023 · Annals of Neurology
  63. Tip-enhanced Raman spectroscopy reveals the structural rearrangements of tau protein aggregates at the growth phase
    Kamila Sofińska, Sara Seweryn, Katarzyna Skirlińska‐Nosek, Jakub Barbasz, Ewelina W. Lipiec · 2024 · Nanoscale
  64. Absence of Uptake and Prion-Like Spreading of Alpha-Synuclein and Tau After Intravitreal Injection of Preformed Fibrils
    Lien Veys, Jessie Van houcke, Jeroen Aerts, Sophie Van Pottelberge, Michel Mahieu, Audrey Coens, Ronald Melki, Dieder Moechars, Louis De Muynck, Lies De Groef · 2021 · Frontiers in Aging Neuroscience
  65. Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer’s Disease
    Sean Tok, Hervé Maurin, C. Delay, Dries Crauwels, Nikolay V. Manyakov, Wim Van der Elst, Diederik Moechars, Wilhelmus H. I. M. Drinkenburg · 2022 · Acta Neuropathologica Communications
  66. Partial Destabilization of Amyloid-β Protofibril by Methionine Photo-Oxidation: A Molecular Dynamic Simulation Study
    Fahimeh Maghsoodi, Tye D. Martin, Eva Y. Chi · 2023 · ACS Omega
  67. Rare forms of cerebral amyloid angiopathy: pathogenesis, biological and clinical features of CAA-ri and iCAA
    Benedetta Storti, Maria Magdalena Gabriel, Stefan Sennfält, Isabella Canavero, Nicola Rifino, Laura Gatti, Anna Bersano · 2023 · Frontiers in Neuroscience
  68. The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target
    Guangtong Liu, Linlin Zhang, Yongzhao Fan, Wenliang Ji · 2023 · Journal of Integrative Neuroscience
  69. Single-domain antibody-based protein degrader for synucleinopathies
    Yixiang Jiang, Yan Lin, Amber M. Tetlow, Ruimin Pan, Changyi Ji, Xiang‐Peng Kong, Erin E. Congdon, Einar M. Sigurdsson · 2024 · Molecular Neurodegeneration
  70. Beyond anosmia: olfactory dysfunction as a common denominator in neurodegenerative and neurodevelopmental disorders
    Yu-Nan Chen, Johanna K. Kostka · 2024 · Frontiers in Neuroscience
  71. Network interdigitations of Tau and amyloid‐beta deposits define cognitive levels in aging
    Chan Mi Kim, Víctor Montal, Ibai Palacio Diez, William Orwig, Alzheimer’s Disease Neuroimaging Initiative, Jorge Sepulcre · 2021 · Human Brain Mapping
  72. Metal nanocomposites for biosensing amyloid beta peptides: Advancing point-of-care diagnostics in Alzheimer's disease
    Bharathi Natarajan, Qiang Zhou, Govindhan Maduraiveeran, Palanisamy Kannan · 2026 · Coordination Chemistry Reviews
  73. Micro/nanoparticle-enabled ultrasound therapy of brain diseases
    Luping Qiu, Zhining Zhu, Jing Liang, Xiaohui Qiao, Huning Xu, Huijing Xiang, Hong Ding, Yu Chen · 2023 · Coordination Chemistry Reviews
  74. The neuroprotection of deproteinized calf blood extractives injection against Alzheimer's disease via regulation of Nrf-2 signaling
    Yidi Qu, Wenqi Wang, Tianrui Chen, Yumin Yang, Yizhi Zhang, Di Wang · 2021 · Aging
  75. Toxicities of amyloid-beta and tau protein are reciprocally enhanced in the Drosophila model
    Zhen-Dong Sun, Jia-Xin Hu, Jia-Rui Wu, Bing Zhou, Jiaxin Hu · 2022 · Neural Regeneration Research
  76. Focus on Alzheimer’s Disease: The Role of Fibroblast Growth Factor 21 and Autophagy
    Lan Yang, Jianfei Nao · 2022 · Neuroscience
  77. The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
    Guanying You, Jinyi Yao, Qiong Liu, Nan Li · 2022 · Current Issues in Molecular Biology
  78. Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies
    Kimberly L. Fiock, Ryan K. Betters, Marco M. Hefti · 2023 · Journal of Histochemistry & Cytochemistry
  79. Site‐Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding
    Mahmood Haj‐Yahya, Pushparathinam Gopinath, Kolla Rajasekhar, Hilda Mirbaha, Marc I. Diamond, Hilal Ahmed Lashuel · 2019 · Angewandte Chemie
  80. Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort
    Menayit Tamrat Dresse, Pâmela C.L. Ferreira, Akshay Prasadan, Jihui L. Diaz, Xuemei Zeng, Bruna Bellaver, Guilherme Povala, Victor L. Villemagne, M. Ilyas Kamboh, Ann D. Cohen et al. · 2025 · Alzheimer s Research & Therapy
  81. Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
    Neha Basheer, Luc Buée, Jean‐Pierre Brion, Tomáš Smolek, Muhammad Khalid Muhammadi, Jozef Hritz, Tomáš Hromádka, Ilse Dewachter, Susanne Wegmann, Isabelle Landrieu et al. · 2024 · Acta Neuropathologica Communications
  82. Sequence of Molecular Events in the Development of Alzheimer’s Disease: Cascade Interactions from Beta-Amyloid to Other Involved Proteins
    Soghra Bagheri, Ali Akbar Saboury, Luciano Saso · 2024 · Cells
  83. Tau Accumulation Induces Microglial State Alterations in Alzheimer's Disease Model Mice
    Kenichi Nagata, Shoko Hashimoto, Daisuke Joho, Ryo Fujioka, Yukio Matsuba, Misaki Sekiguchi, Naomi Mihira, Daisuke Motooka, Yu‐Chen Liu, Daisuke Okuzaki et al. · 2024 · eNeuro
  84. Anisotropic diffusion and traveling waves of toxic proteins in neurodegenerative diseases
    P. G. Kevrekidis, Travis Thompson, Alain Goriely · 2020 · Physics Letters A
  85. Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer’s Disease
    Agnes Paulus, Anders Engdahl, Yiyi Yang, Antonio Boza‐Serrano, Sara Bachiller, Laura Torres-Garcia, Alexander Svanbergsson, Megg G. Garcia, Gunnar K. Gouras, Jiayi Li et al. · 2021 · International Journal of Molecular Sciences
  86. Trpc6 knockout improves behavioral dysfunction and reduces Aβ production by inhibiting CN-NFAT1 signaling in T2DM mice
    Liangliang Kong, Ranran Sun, Huimsin Zhou, Qifeng Shi, Yan Liu, Min Han, Weiping Li, Sen Qun, Weizu Li · 2023 · Experimental Neurology
  87. Computationally Designed Small Molecules Disassemble Both Soluble Oligomers and Protofibrils of Amyloid β-Protein Responsible for Alzheimer’s Disease
    Yingying Jin, Matthew A. Downey, Ambuj K. Singh, Steven K. Buratto, Michael T. Bowers · 2023 · ACS Chemical Neuroscience
  88. Connectivity, Pathology, and ApoE4 Interactions Predict Longitudinal Tau Spatial Progression and Memory
    Jacob Ziontz, Theresa M. Harrison, Corrina S. Fonseca, Joseph Giorgio, Feng Han, JiaQie Lee, William J. Jagust, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Human Brain Mapping
  89. Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures
    Kerry T. Sun, Sue‐Ann Mok · 2025 · Neurotherapeutics
  90. Amyloid-beta peptide toxicity in the aged brain is a one-way journey into Alzheimer’s disease
    Georgia R. Culley, Alexandre Henriques, Delphine Hardy, Alexandre Wojcinski, Adrien Chabert, Bilal El Waly, Philippe Poindron, Noëlle Callizot · 2025 · Frontiers in Aging Neuroscience
  91. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
    Vanessa Laversenne, Sameer Nazeeruddin, Emma Källstig, Philippe Colin, Christel Voize, Bernard Laurent Schneider · 2020 · Acta Neuropathologica Communications
  92. Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer’s disease
    Ankita Kumari, Abdul Rahaman, Xin‐An Zeng, Zulqarnain Baloch · 2024 · Molecular Therapy — Nucleic Acids
  93. A decade progress in the phenotyping of App knock-in mouse model of Alzheimer’s disease
    Tatsuya Manabe, Takashi Saito · 2025 · Neuroscience Research
  94. Circadian rhythms and the light‐dark cycle interact to regulate amyloid‐beta plaque accumulation and tau phosphorylation in 5xFAD mice
    Melvin W. King, Sophie M. Jacob, Ashish Sharma, Jennifer H. Lawrence, Erik S. Musiek · 2025 · Alzheimer s & Dementia
  95. Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline
    Shieh‐Yueh Yang, Huei-Chun Liu, Wen-Ping Chen · 2020 · Neurology and Therapy
  96. Body mass index related to executive function and hippocampal subregion volume in subjective cognitive decline
    Ruilin Chen, Guiyan Cai, Shurui Xu, Qianqian Sun, Jia Luo, Yajun Wang, Ming Li, Hui Lin, Jiao Liu · 2022 · Frontiers in Aging Neuroscience
  97. Therapeutic Mechanism of Kai Xin San on Alzheimer’s Disease Based on Network Pharmacology and Experimental Validation
    Kan Wang, Rong Yang, Tuan-tuan Chen, Meirong Qin, Ping Wang, Mingwang Kong · 2022 · Chinese Journal of Integrative Medicine
  98. Early Chronic Stress Induced Changes within the Locus Coeruleus in Sporadic Alzheimer’s Disease
    Donné Minné, Jeanine Lucasta Marnewick, Penelope C. Engel-Hills · 2023 · Current Alzheimer Research
  99. Network analysis of S-nitrosylated synaptic proteins demonstrates unique roles in health and disease
    Morgan G. Stykel, Scott D. Ryan · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  100. Recent advances in nanoenzymes for Alzheimer's disease treatment
    Xiaojun Bi, Ning Cao, Jingteng He · 2024 · Colloids and Surfaces B Biointerfaces